Bluejay Diagnostics, Inc. 8-K

What Happened
Bluejay Diagnostics, Inc. (BJDX) filed a Form 8-K on March 16, 2026 under Item 7.01 (Regulation FD Disclosure) to furnish a response letter sent to NorthStrive Fund II LP on March 13, 2026. The response letter was sent after the Company received a letter from NorthStrive dated March 11, 2026. A copy of the Company’s response is included as Exhibit 99.1 to the filing.

Key Details

• Item reported: 7.01 — Regulation FD Disclosure (response to investor communication).
• Date of Company response: March 13, 2026.
• Date of original letter from NorthStrive: March 11, 2026.
• Exhibit included: 99.1 — Letter to NorthStrive Fund II LP (furnished with the 8-K).
• Filing date: March 16, 2026 (Form 8-K).

Why It Matters
This 8-K makes Bluejay’s correspondence with an activist investor publicly available, ensuring equal public access under Regulation FD. Retail investors can read Exhibit 99.1 to see the Company’s position and any substance of the exchange. While the filing itself does not announce financial results or corporate actions, communications with activist investors can be relevant to governance, strategy, and potential future disclosures, so shareholders may want to review the attached letter for specifics.